Cargando…

Development and Characterization of an HCMV Multi-Antigen Therapeutic Vaccine for Glioblastoma Using the UNITE Platform

Glioblastoma multiforme (GBM) is an aggressive form of brain cancer with a median survival of 15 months that has remained unchanged despite advances in the standard of care. GBM cells express human cytomegalovirus (HCMV) proteins, providing a unique opportunity for targeted therapy. We utilized our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adhikari, Amit S., Macauley, Juliete, Johnson, Yoshimi, Connolly, Mike, Coleman, Timothy, Heiland, Teri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149224/ https://www.ncbi.nlm.nih.gov/pubmed/35651802 http://dx.doi.org/10.3389/fonc.2022.850546

Ejemplares similares

Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
por: Kim, M. N., et al.
Publicado: (1994)

Characterization of a live-attenuated HCMV-based vaccine platform
por: Caposio, Patrizia, et al.
Publicado: (2019)

Hydrocephalus Shunting in Supratentorial Glioblastoma: Functional Outcomes and Management
por: El Rahal, Amir, et al.
Publicado: (2022)

HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients
por: Zavaglio, Federica, et al.
Publicado: (2023)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells
por: Dong, Xiao-Dong, et al.
Publicado: (2023)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Increased infiltration and tolerised antigen-specific CD8(+) T(EM) cells in tumor but not peripheral blood have no impact on survival of HCMV(+) glioblastoma patients
por: Bahador, M., et al.
Publicado: (2017)

Inflammatory Breast Cancer: The Secretome of HCMV(+) Tumor-Associated Macrophages Enhances Proliferation, Invasion, Colony Formation, and Expression of Cancer Stem Cell Markers
por: Mohamed, Hossam Taha, et al.
Publicado: (2022)

Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma
por: Kong, Benjamin Y, et al.
Publicado: (2022)

Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma
por: Li, Chao, et al.
Publicado: (2019)

Insight for Immunotherapy of HCMV Infection
por: Long, Xinmiao, et al.
Publicado: (2021)

Human Cytomegalovirus (HCMV)-infected Astrocytoma Cells Impair the Function of HCMV-specific Cytotoxic T Cells
por: Kim, Jiyeon, et al.
Publicado: (2020)

HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation
por: Cobbs, Charles, et al.
Publicado: (2014)

Metabolic Reprogramming of Glioblastoma Cells during HCMV Infection Induces Secretome-Mediated Paracrine Effects in the Microenvironment
por: Harrison, Mark A. A., et al.
Publicado: (2022)

Multi-Omics Analysis of Glioblastoma and Glioblastoma Cell Line: Molecular Insights Into the Functional Role of GPR56 and TG2 in Mesenchymal Transition
por: Ganesh, Raksha A., et al.
Publicado: (2022)

Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis
por: Jang, Jong Keon, et al.
Publicado: (2022)

CryJ-LAMP DNA Vaccines for Japanese Red Cedar Allergy Induce Robust Th1-Type Immune Responses in Murine Model
por: Su, Yan, et al.
Publicado: (2016)

Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections
por: Moazen, Bahareh, et al.
Publicado: (2016)

Modulation of Homology-Directed Repair in T98G Glioblastoma Cells Due to Interactions between Wildtype p53, Rad51 and HCMV IE1-72
por: Kulkarni, Amit S., et al.
Publicado: (2014)

Area-level socioeconomic status is positively correlated with glioblastoma incidence and prognosis in the United States
por: Gorenflo, Maria P., et al.
Publicado: (2023)

A Viral Pilot for HCMV Navigation?
por: Adler, Barbara
Publicado: (2015)

HCMV latency: what regulates the regulators?
por: Elder, Elizabeth, et al.
Publicado: (2019)

HCMV Envelope Glycoprotein Diversity Demystified
por: Foglierini, Mathilde, et al.
Publicado: (2019)

Challenging the Conventional Interpretation of HCMV Seronegativity
por: Waters, Shelley, et al.
Publicado: (2021)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Variants of HCMV UL18 Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMV
por: Waters, Shelley, et al.
Publicado: (2022)

Multi-task learning-based feature selection and classification models for glioblastoma and solitary brain metastases
por: Huang, Ya, et al.
Publicado: (2022)

Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
por: Rajani, Karishma R., et al.
Publicado: (2019)

The microRNA Transcriptome of Human Cytomegalovirus (HCMV)
por: Meshesha, Mesfin K, et al.
Publicado: (2012)

Increased HCMV seroprevalence in patients with hepatocellular carcinoma
por: Lepiller, Quentin, et al.
Publicado: (2011)

US28: HCMV’s Swiss Army Knife
por: Krishna, Benjamin A., et al.
Publicado: (2018)

Tuning the Orchestra: HCMV vs. Innate Immunity
por: Dell’Oste, Valentina, et al.
Publicado: (2020)

Intragenic variations in the HCMV RL11-family
por: Sekulin, K., et al.
Publicado: (2006)

Small Molecules—Prospective Novel HCMV Inhibitors
por: Bogner, Elke, et al.
Publicado: (2021)

CARs—A New Perspective to HCMV Treatment
por: Bednar, Christopher, et al.
Publicado: (2021)

HCMV Antivirals and Strategies to Target the Latent Reservoir
por: Perera, Marianne R., et al.
Publicado: (2021)

Targeting Selectins and Their Ligands in Cancer
por: Natoni, Alessandro, et al.
Publicado: (2016)

Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
por: Falk, Jessica Julia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ik076gpb9e7u1r58q5mkpd2rp0